Circulating tumor DNA for predicting complete response to total neoadjuvant therapy in locally advanced rectal cancer: ENSEMBLE-2. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...
News Medical on MSN6d
Study reveals sex-specific differences in microglial response to CSF1R inhibitionResearchers investigate the sex-dependent microglial response to a colony-stimulating factor 1 receptor (CSF1R) inhibitor.
More information: Jaroslaw Dulski et al, Global Presence and Penetrance of CSF1R -Related Disorder, Neurology Genetics (2024). DOI: 10.1212/NXG.0000000000200187 Provided by Mayo Clinic ...
1 月 15 日，CDE 官网显示，第一三共新药盐酸吡昔替尼胶囊（PLX3397,Pexidartinib）报上市，适应症为治疗伴有重度病变或功能受限且无法通过手术改善的症状性腱鞘巨细胞瘤（TGCT）成年患者，此前已正式纳入优先审评。这是目前全球首个也是唯一一个获批治疗 TGCT 的药物。截图来源：CDE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback